FOXP3 and prostate carcinoma: Double immunofluorescence analysis confirmed that Foxp3+ Tregs expressed CCR4 in the tumor microenvironment (figure 2I), indicating that CCL17–CCR4 axis possibly contributes to the infiltration of Tregs into canine prostate cancer tissues.